ARCALYST Uptake And Pipeline Progress Will Expand Rare Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
23 Aug 25
Updated
23 Aug 25
AnalystHighTarget's Fair Value
US$55.00
39.9% undervalued intrinsic discount23 Aug
US$33.04
1Y
19.9%7D
-2.0%1Y
19.9%7D
-2.0%